Updates are available Correction dated 2020-04-20
Click to view Correction: https://doi.org/10.1007/s00436-020-06685-5
-
Authors
Zaki, Paul
Domingues, Elisa LBC
Amjad, Farhad M
Narde, Maiara B
Gonçalves, Karolina R
Viana, Mirelle L
de Paula, Heberth
de Lima, Wanderson G
Huang, Huan
Bahia, Maria T
Sherer, Philipp E
dos Santos, Fabiane M
Weiss, Louis M
Tanowitz, Herbert B
-
Funding
Funding for this research was provided by:
Fundação Estadual de Amparo à Pesquisa do Estado do Espírito Santo (565/2015)
United States of America National Institute of Allergy and Infectious Diseases (AI124000)
National Institute of Allergy and Infectious Diseases (AI124000)
- License Information
-
More Information
Article History
Received: 14 November 2019
Accepted: 28 February 2020
First Online: 24 March 2020
Change Date: 20 April 2020
Change Type: Correction
Change Details: The authors regret that Philipp E Scherer’s name was spelt incorrectly in the author list. The name of the author is now corrected above.
Compliance with ethical standards
: All animal procedures and experimental protocols concerning experiments with transgenic aP2-RID α/β mouse model and Aif-1 target inactivated mouse model were approved by the Institutional Animal Care and Use Committees (IACUC) of Albert Einstein College of Medicine (No. 20151206) and conducted in accordance with the guidelines of the National Research Council (Guide for Care and Use of Laboratory Animals: Eight Edition, Washington, DC: The National Academic Press, 2011).
: All procedures or experimental protocols conducted in the <i>Swiss</i> mouse model were performed according to CONCEA (National Council for Control of Animal Experimentation) and behavior instructions for the use of animals in research from Brazil. The experiment with <i>Swiss</i> mouse model was also previously approved by the Ethics Committee on the Use of Animals of the Federal University of Espírito Santo (protocol number 43/2015).
